Home / Stocks / Sanofi India Limited
SANOFI

Sanofi India Limited Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹3,202.5

Change

-29.3 (-0.91%)

Open

₹3,245.0

Prev. Close

₹3,231.8

Day High

₹3,245.0

Day Low

₹3,190.8

Volume Analysis

Traded

9,501

Delivered

5,466

Delivery %

57.53%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (2)

  • •Strong return on equity (47.1%)
  • •Strong operating margin (24.0%)

Weaknesses (0)

No signal for this stock

Opportunities (0)

No signal for this stock

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹3,288.94 ₹3,266.97 ₹3,234.74 ₹3,212.77 ₹3,180.54 ₹3,158.57 ₹3,126.34
Fibonacci ₹3,266.97 ₹3,246.27 ₹3,233.47 ₹3,212.77 ₹3,192.07 ₹3,179.27 ₹3,158.57
Camarilla ₹3,217.41 ₹3,212.44 ₹3,207.47 ₹3,212.77 ₹3,197.53 ₹3,192.56 ₹3,187.6

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-21.85%

1 Week

-2.39%

1 Month

+13.27%

3 Months

-4.48%

6 Months

+1.24%

1 Year

-29.91%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹1,506.86

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

44.54%

Net margin 20.52% × asset turnover 1.34x × equity multiplier 1.62x

Company Overview

Sector

Healthcare

Market Cap

₹7,375 Cr

P/E (TTM)

16.7

ROE

47.1%

Book Value

₹374.0

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 20 Nov 2026. Not investment advice.

TopFund Analysis

Sanofi India Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 57/100. The strongest factor is Financial Strength (100/100), while Growth (0/100) is the weakest area to weigh before deciding. Notably: Strong return on equity (47.1%); strong operating margin (24.0%). FII holding has been falling.

TopFund Score — Fundamentals Quality

57/100 — Average

Data confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

0

Valuation

34

Cash Flow

76

Corporate Governance

77

Momentum

24

Institutional Ownership

28

Business Quality

99

Risk & Volatility

57

Liquidity

44

From Screener.in

  • +Company is almost debt free.
  • +Company's working capital requirements have reduced from 27.6 days to 20.4 days
  • −Stock is trading at 8.56 times its book value
  • −Debtor days have increased from 32.9 to 41.7 days.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Bengaluru GST show cause notice dropped; Sanofi India pays Rs.17,680 tax and interest on 16 November 2026.

Sanofi India declared Rs 75 interim dividend for FY2026; record date 5 November 2026.

Sanofi India reported Q3 FY2026 results and declared ₹75 interim dividend; record date is 5 November 2026.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
Sales + 515 491 469 511 464 524 515
Expenses + 393 377 370 374 348 404 397
Operating Profit 122 114 100 137 116 120 118
OPM % 24.0% 23.0% 21.0% 27.0% 25.0% 23.0% 23.0%
Other Income + 57 82 77 41 21 2 14
Interest 1 0 0 0 0 0 0
Depreciation 9 9 9 9 9 9 10
Profit before tax 169 186 167 169 127 113 122
Tax % 27.0% 18.0% 18.0% 19.0% 19.0% 27.0% 25.0%
Net Profit + 123 152 138 137 103 82 91
EPS in Rs 53 66 60 59 45 36 40
Raw PDF — — — — — — —
YoY Sales growth — — — — -10 7 10

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Dec 2014 (S) Dec 2015 (S) Dec 2016 (S) Dec 2017 (S) Dec 2018 (S) Dec 2019 (S) Dec 2020 (S) Dec 2021 (S) Dec 2022 (S) Dec 2023 Dec 2024
Sales + 1,977 2,193 2,367 2,460 2,771 3,071 2,902 2,957 2,770 1,996 2,013
Expenses + 1,639 1,817 1,832 1,921 2,146 2,403 2,186 2,194 2,066 1,508 1,522
Operating Profit 339 376 535 538 625 667 716 762 704 488 491
OPM % 17.0% 17.0% 23.0% 22.0% 23.0% 22.0% 25.0% 26.0% 25.0% 24.0% 24.0%
Other Income + 131 218 66 79 88 33 45 564 204 317 78
Interest 0 0 2 1 1 0 2 2 2 2 2
Depreciation 97 113 119 102 103 100 82 67 42 36 37
Profit before tax 373 481 480 515 610 600 677 1,258 864 767 531
Tax % 29.0% 33.0% 37.0% 37.0% 38.0% 31.0% 29.0% 25.0% 28.0% 21.0% 22.0%
Net Profit + 264 322 304 326 381 414 478 944 621 603 413
EPS in Rs 115 140 132 142 165 180 208 411 270 262 180
Dividend Payout % 39.0% 46.0% 51.0% 50.0% 51.0% 194.0% 176.0% 119.0% 211.0% 64.0% 65.0%
Sales growth 9 11 8 4 13 11 -5 2 -6 — 1

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Dec 2014 (S) Dec 2015 (S) Dec 2016 (S) Dec 2017 (S) Dec 2018 (S) Dec 2019 (S) Dec 2020 (S) Dec 2021 (S) Dec 2022 (S) Dec 2023 Dec 2024
Reserves 1,463 1,604 1,860 2,003 2,196 2,419 2,096 2,203 1,253 992 838
Borrowings + 0 0 0 0 0 0 23 25 24 19 19
Other Liabilities + 742 778 658 751 765 802 777 811 772 681 732
Total Liabilities 2,228 2,405 2,541 2,778 2,984 3,244 2,918 3,061 2,072 1,715 1,612
Fixed Assets + 648 877 817 769 733 499 464 334 306 315 312
CWIP 210 22 34 30 21 17 10 13 24 16 18
Investments 0 0 0 0 0 0 0 0 0 0 0
Other Assets + 1,369 1,505 1,690 1,978 2,230 2,728 2,444 2,714 1,743 1,384 1,281
Total Assets 2,228 2,405 2,541 2,778 2,984 3,244 2,918 3,061 2,072 1,715 1,612
Equity Capital 23 23 23 23 23 23 23 23 23 23 23

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Dec 2014 (S) Dec 2015 (S) Dec 2016 (S) Dec 2017 (S) Dec 2018 (S) Dec 2019 (S) Dec 2020 (S) Dec 2021 (S) Dec 2022 (S) Dec 2023 Dec 2024
Cash from Operating Activity + 265 213 322 435 374 412 611 559 399 230 462
Cash from Investing Activity + 61 36 -155 -79 -73 66 276 631 651 38 -180
Cash from Financing Activity + -122 -147 -180 -188 -197 -183 -810 -849 -1,583 -878 -392
Net Cash Flow 205 102 -13 168 104 295 78 341 -533 -610 -111
Free Cash Flow 247 184 253 379 317 337 810 574 412 220 426
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 114 93 101 118 99 96 112 111 94 97 114

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 60.4% → 60.4%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 10.78% 10.61% 11.21% 11.2% 11.04% 11.01% 10.94% 11.75% 12.75% 12.84% 14.05% 14.46%
Promoters 60.4% 60.4% 60.4% 60.4% 60.4% 60.4% 60.4% 60.4% 60.4% 60.4% 60.4% 60.4%
FII 6.31% 6.11% 5.81% 5.78% 5.64% 5.58% 5.61% 5.57% 5.55% 5.65% 5.69% 5.73%
DII 22.51% 22.88% 22.6% 22.62% 22.94% 23.02% 23.06% 22.28% 21.3% 21.12% 19.87% 19.4%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Sanofi India Limited (this stock) 7,375 16.7 8.56 47.1%
Kovai Medical Center & Ho 7,108 123.0 24.58 22.2%
Bliss Gvs Pharma Ltd 7,075 43.5 5.5 11.8%
Suven Life Sciences Ltd 7,850 — 17.38 -81.5%
Thyrocare Tech Ltd 7,940 45.3 14.31 28.4%
Sun Pharma Adv.res.co.ltd 6,680 4.05 4.64 279.0%
Nephrocare Health Serv L 6,500 50.8 5.46 8.83%

Which Mutual Funds Hold Sanofi India Limited?

Frequently Asked Questions about Sanofi India Limited

Community Sentiment

What are other investors saying about Sanofi India Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.